Literature DB >> 12132586

Hepatitis C virus core inhibits the Fas-mediated p38 mitogen activated kinase signaling pathway in hepatocytes.

Se-Hwan Yang1, Chang Geun Lee, Chang Woo Lee, Eui-Ju Choi, Seung Kew Yoon, Kwang Seog Ahn, Young Chul Sung.   

Abstract

The p38 mitogen activated kinase (MAPK) signaling pathway plays an essential role in regulating many cellular processes, including inflammation, cell differentiation, and cell death. Here, we report that the hepatitis C virus (HCV) core inhibits the Fas-mediated p38 signaling pathway. The Fas-mediated p38 activation is suppressed in core-expressing HepG2 cell lines, as well as in the hepatocytes of transgenic mice. In addition, core protein blocked the Fas-mediated activation of apoptosis signal-regulating kinase 1 (ASK1), a major upstream MAPKKK of p38. Treatment of a specific p38 inhibitor (SB203580) or overexpression of a kinase-defective mutant, ASK1 (K709R), promoted Fas-mediated cell death in HepG2 cells. This suggests that the p38 and ASK1 activation is required for cell survival against Fas-mediated cell death. In addition, we observed that the HCV core protein enhances Fas-mediated liver injury and lethality in transgenic mice. Collectively, our findings suggest that the HCV core inhibits the Fas-mediated p38 signaling pathway, which results in accelerated Fas-mediated cell death.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12132586

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  6 in total

1.  HCV-specific interleukin-21+CD4+ T cells responses associated with viral control through the modulation of HCV-specific CD8+ T cells function in chronic hepatitis C patients.

Authors:  Guohua Feng; Ji-Yuan Zhang; Qing-Lei Zeng; Lei Jin; Junliang Fu; Bin Yang; Ying Sun; Tianjun Jiang; Xiangsheng Xu; Zheng Zhang; Jinhong Yuan; Liyuan Wu; Fu-Sheng Wang
Journal:  Mol Cells       Date:  2013-10-22       Impact factor: 5.034

2.  Identification of Piperazinylbenzenesulfonamides as New Inhibitors of Claudin-1 Trafficking and Hepatitis C Virus Entry.

Authors:  Laura Riva; Ok-Ryul Song; Jannick Prentoe; François Helle; Laurent L'homme; Charles-Henry Gattolliat; Alexandre Vandeputte; Lucie Fénéant; Sandrine Belouzard; Thomas F Baumert; Tarik Asselah; Jens Bukh; Priscille Brodin; Laurence Cocquerel; Yves Rouillé; Jean Dubuisson
Journal:  J Virol       Date:  2018-04-27       Impact factor: 5.103

3.  Cre-estrogen receptor-mediated hepatitis C virus structural protein expression in mice.

Authors:  Batbayar Tumurbaatar; Yixiao Sun; Tehsheng Chan; Jiaren Sun
Journal:  J Virol Methods       Date:  2007-07-12       Impact factor: 2.014

4.  Apoptotic effects of a chimeric plant virus carrying a mimotope of the hepatitis C virus hypervariable region 1: role of caspases and endoplasmic reticulum-stress.

Authors:  G Piazzolla; M Nuzzaci; A Vitti; N Napoli; M Schiavone; P Piazzolla; S Antonaci; C Tortorella
Journal:  J Clin Immunol       Date:  2012-03-06       Impact factor: 8.317

5.  Modulation of Cell Death Pathways by Hepatitis C Virus Proteins in Huh7.5 Hepatoma Cells.

Authors:  Olga V Masalova; Ekaterina I Lesnova; Pavel N Solyev; Natalia F Zakirova; Vladimir S Prassolov; Sergey N Kochetkov; Alexander V Ivanov; Alla A Kushch
Journal:  Int J Mol Sci       Date:  2017-11-06       Impact factor: 5.923

Review 6.  Modulation of signaling pathways by RNA virus capsid proteins.

Authors:  Matthew D Urbanowski; Carolina S Ilkow; Tom C Hobman
Journal:  Cell Signal       Date:  2008-01-04       Impact factor: 4.315

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.